Search

Author/Creator Qureshi, Anila

1. Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study. Issue 12 (22nd October 2019)

Authors:
Yokota, Kenji; Uchi, Hiroshi; Uhara, Hisashi; Yoshikawa, Shusuke; Takenouchi, Tatsuya; Inozume, Takashi; Ozawa, Kentaro; Ihn, Hironobu; Fujisawa, Yasuhiro; Qureshi, Anila; de Pril, Veerle; Otsuka, Yasushi; Weber, Jeffrey; Yamazaki, Naoya
Journal:
Journal of dermatology
Issue:
Volume 46:Issue 12(2019)
Page Start:
1197
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial. Issue 5 (May 2017)

Authors:
Ascierto, Paolo A; Del Vecchio, Michele; Robert, Caroline; Mackiewicz, Andrzej; Chiarion-Sileni, Vanna; Arance, Ana; Lebbé, Céleste; Bastholt, Lars; Hamid, Omid; Rutkowski, Piotr; McNeil, Catriona; Garbe, Claus; Loquai, Carmen; Dreno, Brigitte; Thomas, Luc; Grob, Jean-Jacques; Liszkay, Gabriella;...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 5(2017:May)
Page Start:
611
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search